MedTrace Logo

Effects of the SIS Membrane on GBR and Early Loading of Maxillary Anterior Dental Implants

NCT06574815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-08-30

No results posted yet for this study

Summary

The aim of this randomized controlled trial (RCT) is to determine whether early implant loading that shortens the healing period to 6 weeks can be safely and effectively applied to implants with good initial stability in the maxillary anterior region, which undergoes simultaneous guided bone regeneration (GBR), via clinical examination, intraoral scanning, imageological diagnosis, and aesthetic scoring, and to determine the clinical effect of the small intestine submucosa (SIS) biological barrier membrane in such cases involving early loading. This study is expected to provide preliminary guidance on the timing of loading for a single maxillary anterior implant with insufficient bone volume and provide a theoretical basis for the selection of a biological barrier membrane for GBR in such patients.

Conditions

  • Dental Implantation
  • Guided Bone Regeneration

Interventions

PROCEDURE

Early implant loading

Patients underwent definitive restoration at 6 weeks after implant surgery (early loading).

PROCEDURE

Delayed implant loading

Patients underwent definitive restoration at 6 months after implant surgery (delayed loading).

PROCEDURE

GBR using an SIS membrane

An small intestine submucosa (SIS) membrane was used in the guided bone regeneration (GBR) surgery.

PROCEDURE

GBR using an Bio-Gide membrane

An Bio-Gide membrane was used in the guided bone regeneration (GBR) surgery.

Sponsors & Collaborators

  • Beijing Stomatological Hospital, Capital Medical University

    lead OTHER

Principal Investigators

  • Chao Liang, PhD · Beijing Stomatological Hospital, Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2024-08-02
Completion
2024-08-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06574815 on ClinicalTrials.gov